CLINICAL_TRIALS
trial_result
· 2019-10-02
Clinical Trial Update: PMS of Trazenta on the Long-term Use as Add-on Therapy
Summary
A completed clinical trial update on long-term use of Trazenta as add-on therapy for type 2 diabetes; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2019-10-02